{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:41Z","timestamp":1777866281992,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP7480"],"award-info":[{"award-number":["OPP7480"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127698","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:02:34Z","timestamp":1758132154000},"page":"127698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers"],"prefix":"10.1016","volume":"64","author":[{"given":"Abraham","family":"Hodgson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadima Cheick","family":"Haidara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samba O.","family":"Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Odum","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana Akosua","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagritos D.","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Bangre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin C.","family":"Enwere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Stanzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Plikaytis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Parulekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Martellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Chaumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fran\u00e7oise","family":"Makadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Carlone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Marc","family":"LaForce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2025.127698_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00006454-198303000-00003","article-title":"Long term sequelae of bacterial meningitis in children","volume":"2","author":"Sell","year":"1983","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127698_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-7-47","article-title":"Sequelae due to bacterial meningitis among African children: a systematic literature review","volume":"7","author":"Ramakrishnan","year":"2009","journal-title":"BMC Med"},{"issue":"33","key":"10.1016\/j.vaccine.2025.127698_bb0015","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1016\/j.vaccine.2011.05.058","article-title":"Costs and impact of meningitis epidemics for the public health system in Burkina Faso","volume":"29","author":"Colombini","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127698_bb0020","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96","volume":"77","author":"Campagne","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"8390","key":"10.1016\/j.vaccine.2025.127698_bb0025","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(84)91830-0","article-title":"Meningococcal disease and season in sub-Saharan Africa","volume":"1","author":"Greenwood","year":"1984","journal-title":"Lancet Lond Engl"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127698_bb0030","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The meningitis vaccine project","volume":"25","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127698_bb0035","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal a conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127698_bb0040","doi-asserted-by":"crossref","first-page":"S507","DOI":"10.1093\/cid\/civ626","article-title":"A phase 3, double-blind, randomized, active controlled study to evaluate the safety of MenAfriVac in healthy Malians","volume":"61 Suppl 5(Suppl 5)","author":"Tapia","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127698_bb0045","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2012.08.004","article-title":"Immunogenicity and safety of a new meningococcal a conjugate vaccine in Indian children aged 2\u201310 years: a phase II\/III double-blind randomized controlled trial","volume":"30","author":"Hirve","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2025.127698_bb0065","doi-asserted-by":"crossref","first-page":"S531","DOI":"10.1093\/cid\/civ601","article-title":"Influence of age on antibody response and persistence following immunization with MenAfriVac","volume":"61","author":"Tang","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2025.127698_bb0070","doi-asserted-by":"crossref","first-page":"S570","DOI":"10.1093\/cid\/civ512","article-title":"MenAfriVac as an Antitetanus vaccine","volume":"61","author":"Borrow","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127698_bb0075","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1093\/cid\/civ603","article-title":"Immunogenicity of yellow fever vaccine Coadministered with MenAfriVac in healthy infants in Ghana and Mali","volume":"61 Suppl 5(Suppl 5)","author":"Roy Chowdhury","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127698_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"issue":"28","key":"10.1016\/j.vaccine.2025.127698_bb0085","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.vaccine.2018.05.046","article-title":"Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: a phase III, randomized study","volume":"36","author":"Dbaibo","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127698_bb0090","series-title":"Plotkin\u2019s Vaccines (Seventh Edition)","article-title":"38 - Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines [Internet]","author":"Harrison","year":"2018"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127698_bb0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1017\/S0950268805005339","article-title":"The natural history of meningococcal carriage and disease","volume":"134","author":"Trotter","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127698_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127698_bb0105","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127698_bb0110","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.162.6.1837","article-title":"Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group a capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies","volume":"162","author":"Guirguis","year":"1985","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127698_bb0115","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/iai.13.6.1654-1662.1976","article-title":"Bacillus pumilus polysaccharide cross-reactive with meningococcal group a polysaccharide","volume":"13","author":"Vann","year":"1976","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127698_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/iai.6.5.651-656.1972","article-title":"Enteric bacteria cross-reactive with Neisseria meningitidis groups a and C and diplococcus pneumoniae types I and 3","volume":"6","author":"Robbins","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127698_bb0125","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/civ518","article-title":"Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2\u201329 Years","volume":"61 Suppl 5(Suppl 5)","author":"Diallo","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127698_bb0130","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2012.08.004","article-title":"Immunogenicity and safety of a new meningococcal a conjugate vaccine in Indian children aged 2\u201310 years: a phase II\/III double-blind randomized controlled trial","volume":"30","author":"Hirve","year":"2012","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127698_bb0135","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal a conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127698_bb0140","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00068-09","article-title":"Investigation of different group a immunoassays following one dose of meningococcal group a conjugate vaccine or a\/C polysaccharide vaccine in adults","volume":"16","author":"Findlow","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"35","key":"10.1016\/j.vaccine.2025.127698_bb0145","first-page":"349","article-title":"WHO position paper","volume":"84","author":"Measles vaccines","year":"2009","journal-title":"Releve Epidemiol Hebd"},{"key":"10.1016\/j.vaccine.2025.127698_bb0155","series-title":"Global Plan of Action for New and Under-Utilized Vaccines Implementation: 2008-2011","author":"WHO","year":"2008"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127698_bb0160","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(17)30301-8","article-title":"Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data","volume":"17","author":"Trotter","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127698_bb0165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic group a meningococcal meningitis in Africa through a new vaccine","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Aff Proj Hope"},{"key":"10.1016\/j.vaccine.2025.127698_bb0170","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the African Meningitis Belt, 2004-2013","volume":"61 Suppl 5(Suppl 5)","author":"Lingani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127698_bb0175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup a meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"9911","key":"10.1016\/j.vaccine.2025.127698_bb0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup a meningococcal conjugate vaccine (PsA\u2013TT) on serogroup a meningococcal meningitis and carriage in Chad: a community study","volume":"383","author":"Daugla","year":"2013","journal-title":"Lancet Lond Engl"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2025.127698_bb0185","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/cid\/civ508","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African Meningitis Belt","volume":"61","author":"Karachaliou","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"39","key":"10.1016\/j.vaccine.2025.127698_bb0190","first-page":"551","article-title":"Control of epidemic meningitis in countries in the African meningitis belt, 2023 = Lutte contre la m\u00e9ningite \u00e9pid\u00e9mique dans les pays de la ceinture africaine de la m\u00e9ningite, 2023","volume":"99","author":"Sant\u00e9 WHO= O mondiale de la","year":"2024","journal-title":"Wkly Epidemiol Rec Relev\u00e9 \u00c9pid\u00e9miologique Hebd"},{"key":"10.1016\/j.vaccine.2025.127698_bb0195","unstructured":"Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, Greig J. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14. PLoS Curr 2014;6:ecurrents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518."},{"issue":"10","key":"10.1016\/j.vaccine.2025.127698_bb0200","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid2210.160468","article-title":"Whole-genome characterization of epidemic Neisseria meningitidis serogroup C and resurgence of serogroup W, Niger, 2015","volume":"22","author":"Kretz","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127698_bb0205","first-page":"189","article-title":"A review of the epidemiology of invasive meningococcal disease and vaccination strategies in North Africa","volume":"104","author":"Taha","year":"2021","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127698_bb0210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ebiom.2019.02.054","article-title":"Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016","volume":"41","author":"Topaz","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127698_bb0215","unstructured":"Serum Institute of India Pvt. Ltd. A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age [Internet]. clinicaltrials.gov; 2021 [cited 2024 Jan 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03295318."},{"key":"10.1016\/j.vaccine.2025.127698_bb0220","unstructured":"Serum Institute of India Pvt. Ltd. A Phase 2\/3, Randomized, Observer-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine (NmCV-5) and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra\u00ae in Healthy Individuals 18-85 Years of Age [Internet]. clinicaltrials.gov; 2021 [cited 2024 Jan 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04358731."},{"issue":"21","key":"10.1016\/j.vaccine.2025.127698_bb0225","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa2214924","article-title":"Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia","volume":"388","author":"Haidara","year":"2023","journal-title":"N Engl J Med"},{"issue":"01\/02","key":"10.1016\/j.vaccine.2025.127698_bb0230","first-page":"1","volume":"99","author":"Sant\u00e9 WHO= O mondiale de la","year":"2024","journal-title":"Wkly Epidemiol Rec Relev\u00e9 \u00c9pid\u00e9miologique Hebd"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:22:07Z","timestamp":1777537327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"alternative-id":["S0264410X25009958"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127698","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127698"}}